Agios Pharmaceuticals (AGIO)

P/S ratio as of January 2026 (TTM): 35.9

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.25. At the end of 2025 the company had a P/S ratio of 50.5.

P/S ratio history for Agios Pharmaceuticals from 2013 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	50.5	-3.24%
2024	52.2	12.47%
2023	46.4	-57.17%
2022	108
2021	N/A	-100%
2020	68.1	145.98%
2019	27.7	-2.61%
2018	28.4	-56.11%
2017	64.8	158.33%
2016	25.1	-39.4%
2015	41.4	-34.91%
2014	63.6	117.43%
2013	29.3

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Pfizer PFE	2.36	-93.42%	🇺🇸 USA
Eli Lilly LLY	15.5	-57.02%	🇺🇸 USA
GSK plc GSK	2.42	-93.27%	🇬🇧 UK
Xencor XNCR	5.28	-85.30%	🇺🇸 USA
Exelixis EXEL	4.97	-86.16%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	3.54	-90.16%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Agios Pharmaceuticals (AGIO)

P/S ratio as of January 2026 (TTM): 35.9